784
Views
17
CrossRef citations to date
0
Altmetric
Research Paper

LncRNA DUXAP10 modulates cell proliferation in esophageal squamous cell carcinoma through epigenetically silencing p21

, , , , &
Pages 998-1005 | Received 11 Dec 2017, Accepted 24 Apr 2018, Published online: 14 Sep 2018

Reference

  • Zhang Q, Wang WW, Xu TH, Xu ZF. Highly expressed long non-coding RNA DUXAP10 promotes proliferation of ovarian cancer. European review for medical and pharmacological sciences 2018; 22:314–21.
  • Xu Y, Yu X, Wei C, Nie F, Huang M, Sun M. Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and beta-catenin in gastric cancer. Journal of experimental & clinical cancer research: CR 2018; 37:13.
  • Lian Y, Xiao C, Yan C, Chen D, Huang Q, Fan Y, Li Z, Xu H. Knockdown of pseudogene derived from lncRNA DUXAP10 inhibits cell proliferation, migration, invasion, and promotes apoptosis in pancreatic cancer. Journal of cellular biochemistry 2018; 119:3671–82.
  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal for clinicians 2011; 61:69–90.
  • Lam AK. Molecular biology of esophageal squamous cell carcinoma. Critical reviews in oncology/hematology 2000; 33:71–90.
  • Wu CC, Chen CJ. Esophageal carcinoma. The New England journal of medicine 2015; 372:1472.
  • Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malignancies. Seminars in oncology 2004; 31:450–64.
  • Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991; 48:411–20.
  • Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. International journal of cancer 1999; 83:18–29.
  • Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010; 31:27–36.
  • Ma L, Bajic VB, Zhang Z. On the classification of long non-coding RNAs. RNA biology 2013; 10:925–33.
  • Huarte M, Rinn JL. Large non-coding RNAs: missing links in cancer? Human molecular genetics 2010; 19:R152–61.
  • Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Molecular cancer 2011; 10:38.
  • Li X, Wu Z, Mei Q, Li X, Guo M, Fu X, Han W. Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma. Br J Cancer 2013; 109:2266–78.
  • Li JY, Ma X, Zhang CB. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. International journal of clinical and experimental pathology 2014; 7:7938–44.
  • Hao Y, Wu W, Shi F, Dalmolin RJ, Yan M, Tian F, Chen X, Chen G, Cao W. Prediction of long noncoding RNA functions with co-expression network in esophageal squamous cell carcinoma. BMC Cancer 2015; 15:168.
  • Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010; 465:1033–8.
  • Proudfoot N. Pseudogenes. Nature 1980; 286:840–1.
  • Grander D, Johnsson P. Pseudogene-Expressed RNAs: Emerging Roles in Gene Regulation and Disease. Current topics in microbiology and immunology 2016; 394:111–26.
  • Xiao-Jie L, Ai-Mei G, Li-Juan J, Jiang X. Pseudogene in cancer: real functions and promising signature. Journal of medical genetics 2015; 52:17–24.
  • Poliseno L, Marranci A, Pandolfi PP. Pseudogenes in Human Cancer. Frontiers in medicine 2015; 2:68.
  • Ma HW, Xie M, Sun M, Chen TY, Jin RR, Ma TS, Chen QN, Zhang EB, He XZ, De W, et al. The pseudogene derived long noncoding RNA DUXAP8 promotes gastric cancer cell proliferation and migration via epigenetically silencing PLEKHO1 expression. Oncotarget 2017; 8:52211–24.
  • Liu Q, Guo X, Que S, Yang X, Fan H, Liu M, Li X, Tang H. LncRNA RSU1P2 contributes to tumorigenesis by acting as a ceRNA against let-7a in cervical cancer cells. Oncotarget 2017; 8:43768–81.
  • Lv XY, Ma L, Chen JF, Yu R, Li Y, Yan ZJ, Cheng Y, Ma Q. Knockdown of DUXAP10 inhibits proliferation and promotes apoptosis in bladder cancer cells via PI3K/Akt/mTOR signaling pathway. International journal of oncology 2018; 52:288–94.
  • Wei CC, Nie FQ, Jiang LL, Chen QN, Chen ZY, Chen X, Pan X, Liu ZL, Lu BB, Wang ZX. The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer. Oncotarget 2017; 8:5233–46.
  • Zhang F, Peng H. LncRNA-ANCR regulates the cell growth of osteosarcoma by interacting with EZH2 and affecting the expression of p21 and p27. Journal of orthopaedic surgery and research 2017; 12:103.
  • Zhang M, Gao C, Yang Y, Li G, Dong J, Ai Y, Chen N, Li W. Long Noncoding RNA CRNDE/PRC2 Participated in the Radiotherapy Resistance of Human Lung Adenocarcinoma Through Targeting p21 Expression. Oncol Res 2017.
  • Jacq C, Miller JR, Brownlee GG. A pseudogene structure in 5S DNA of Xenopus laevis. Cell 1977; 12:109–20.
  • Graur D, Zheng Y, Azevedo RB. An evolutionary classification of genomic function. Genome biology and evolution 2015; 7:642–5.
  • Balakirev ES, Ayala FJ. Pseudogenes: are they “junk” or functional DNA? Annual review of genetics 2003; 37:123–51.
  • Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nature reviews Genetics 2009; 10:155–9.
  • Groen JN, Capraro D, Morris KV. The emerging role of pseudogene expressed non-coding RNAs in cellular functions. The international journal of biochemistry & cell biology 2014; 54:350–5.
  • Liu Q, Hu X, Zhang X, Dai L, Duan X, Zhou C, Ao Y. The TMSB4 Pseudogene LncRNA Functions as a Competing Endogenous RNA to Promote Cartilage Degradation in Human Osteoarthritis. Mol Ther: the journal of the American Society of Gene Therapy 2016; 24:1726–33.
  • Chen X, Zhu H, Wu X, Xie X, Huang G, Xu X, Li S, Xing C. Downregulated pseudogene CTNNAP1 promote tumor growth in human cancer by downregulating its cognate gene CTNNA1 expression. Oncotarget 2016; 7:55518–28.
  • Scarola M, Comisso E, Pascolo R, Chiaradia R, Marion RM, Schneider C, Blasco MA, Schoeftner S, Benetti R. Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA. Nat Com 2015; 6:7631.
  • Huang MD, Chen WM, Qi FZ, Xia R, Sun M, Xu TP, Yin L, Zhang EB, De W, Shu YQ. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2. J Hematol Oncol 2015; 8:57.
  • Sun M, Nie F, Wang Y, Zhang Z, Hou J, He D, Xie M, Xu L, De W, Wang Z, et al. LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1. Cancer Res 2016; 76:6299–310.
  • Chang CJ, Hung MC. The role of EZH2 in tumour progression. British journal of cancer 2012; 106:243–7.
  • Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van Oudenaarden A, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proceedings of the National Academy of Sciences of the United States of America 2009; 106:11667–72.
  • Sun NX, Ye C, Zhao Q, Zhang Q, Xu C, Wang SB, Jin ZJ, Sun SH, Wang F, Li W. Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer. PLoS One 2014; 9:e100340.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.